Comparative evaluation of the efficacy and safety of ormeloxifene and norethisterone in dysfunctional uterine bleeding

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Efficacy and Safety of Ormeloxifene in Dysfunctional Uterine Bleeding

The study was undertaken to assess the efficacy, safety and acceptability of ormeloxifene in the medical management of Dysfunctional Uterine Bleeding (DUB). Sixty women with DUB were given ormeloxifene 60mg twice a week for 12 weeks and once a week for next 12 weeks. Follow up was done at 3 and 6 months. The primary outcome measures were menstrual blood loss, hemoglobin concentration and endome...

متن کامل

A Study of Ormeloxifene in Case of Dysfunctional Uterine Bleeding

Background: Menorrhagia accounts for 12% of all gynaecology consultations and is one of the most common causes of iron deficiency anaemia in females after nutritional anaemia. Objectives: To evaluate the efficacy and side effects of ormeloxifene in cases of dysfunctional uterine bleeding. Material and Methods: 30 women aged 28-46 years who attended the outpatient gynaecology department in a ter...

متن کامل

A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.

OBJECTIVE This study was carried out to evaluate the efficacy of Ormeloxifene in the pharmacological management of dysfunctional uterine bleeding. DESIGN AND SETTING A prospective study was conducted on women with dysfunctional uterine bleeding, who attended to out - patient department of Obstetrics & Gynaecology in a tertiary care general hospital. MATERIAL AND METHODS Women with DUB were ...

متن کامل

A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia.

This randomized open study compared the efficacy and safety of norethisterone, 5 mg three times a day from day 19 to 26, and danazol, 200 mg daily, in the treatment of dysfunctional uterine bleeding presenting as menorrhagia. Clinical criteria were employed to confirm the diagnosis, and subjective assessment of the condition was performed during one pre-treatment and three treatment cycles. Fou...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Reproduction, Contraception, Obstetrics and Gynecology

سال: 2013

ISSN: 2320-1770

DOI: 10.5455/2320-1770.ijrcog20130617